Form 8-K - Current report:
SEC Accession No. 0001698530-21-000070
Filing Date
2021-07-15
Accepted
2021-07-15 08:39:37
Documents
12
Period of Report
2021-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20210715.htm   iXBRL 8-K 32949
  Complete submission text file 0001698530-21-000070.txt   172100

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20210715.xsd EX-101.SCH 1905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20210715_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20210715_pre.xml EX-101.PRE 13045
5 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20210715_htm.xml XML 10944
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 211091767
SIC: 2834 Pharmaceutical Preparations